Activation of immune cells is regulated by positive and negative signals triggered by activating and inhibitory cell surface immunoreceptors, respectively. Inhibitory receptors are characterized by the immunoreceptor tyrosine-based inhibition motif (ITIM) in their cytoplasmic domains and play an important role in immune regulation by both lymphoid and myeloid cells. Mast cells express the high-affi nity receptor for IgE (FcεRI) and toll-like receptors (TLR) on the cell surface, and play a central role in allergic and non-allergic infl ammations. We identifi ed novel inhibitory immunoglobulin-like receptors, Allergin-1 and CD300a, which are expressed on mast cells. Allergin-1 inhibits mast cell degranulation via suppression of FcεRI-mediated signaling. Allergin-1-defi cient mice showed signifi cantly exacerbated IgE-associated type 1 immediate hypersensitivity reactions. On the other hand, CD300a recognizes phosphatidylserine exposed on the plasma membrane of apoptotic cells and inhibits production of chemoattractants from mast cells in response to LPS stimulation. CD300a-defi cient mice showed signifi cantly prolonged survival after cecum ligation and puncture (CLP). Together, our results suggest that Allergin-1 and CD300a may be candidates as molecular targets for the treatment of mast cell-dependent infl ammatory diseases.